Sharda Crop
Khambatta Securities
Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
---|---|---|---|---|---|---|---|---|---|---|---|
27 Jan 2022 | Sharda Cropchem |
Khambatta Securities
|
798.00 | 566.00 | 602.35 (32.48%) | Target met |
Buy
|
||||
27 Jan 2022 | Sharda Cropchem |
Anand Rathi
|
798.00 | 600.00 | 602.35 (32.48%) | Target met |
Buy
|
||||
24 Jan 2022 | Sharda Cropchem |
Prabhudas Lilladhar
|
798.00 | 570.00 | 525.35 (51.90%) | Target met |
Buy
|
SHARDA CROPCHEM LTD.
Prabhudas Lilladhar
Sharda Cropchem (SHCR) reported strong operational performance in 3QFY22, primarily led by healthy revenue growth across regions. Key highlights are: (1) Volume/Price/FX growth of 51%/26.5%/1% YoY respectively; (2) Gross margin declined 60bps YoY to 33.9% led by higher freight cost; (3) Better operating leverage coupled with superior geographical and product mix has resulted into EBITDA margins expansion of 250bps YoY to 22% (incl. IU&AD write-offs of Rs70mn in 3QFY22); and (4) Working capital days up by 1-day YoY to 72. Citing a positive growth momentum across...
|
|||
20 Jan 2022 | Rallis |
Prabhudas Lilladhar
|
353.50 | 280.00 | 260.80 (35.54%) | Target met |
Hold
|
Q3FY22 Result Update - Better revenue growth offset by cost headwinds - Downgrade to 'HOLD'
Prabhudas Lilladhar
Domestic business up 9% YoY largely from price led growth. Rallis India's (RALI) 3QFY22 results were broadly in line with ours as well as consensus estimates. Key highlights are: 1) domestic revenue grew 9% YoY largely from price-led growth (9MFY22 +12% YoY); while crop care segment was up 13% YoY (9MFY22 +12% YoY); 2) export revenue surged 19% YoY...
|
|||
20 Jan 2022 | Rallis |
ICICI Securities Limited
|
353.50 | 305.00 | 277.30 (27.48%) |
Hold
|
|||||
07 Jan 2022 | UPL |
Edelweiss
|
671.50 | 875.00 | 788.95 (-14.89%) | Pre-Bonus/ Split |
Buy
|
||||
14 Dec 2021 | UPL |
Chola Wealth Direct
|
671.50 | 940.00 | 739.95 (-9.25%) | Pre-Bonus/ Split |
Buy
|
||||
23 Nov 2021 | Valiant Organics |
Monarch Networth Capital Limited
|
412.00 | 1975.00 | 1091.95 (-62.27%) |
Buy
|
Valiant Organics - What's in the price? - Company Update
Monarch Networth Capital Limited
PAP: Valiant is currently producing PAP in small quantities (~100MT/m) and is working towards continuous PAP production as the same would result in reduction in overheads. Going forward, the management highlighted that they should be able...
|
||||
16 Nov 2021 | PI Industries |
Chola Wealth Direct
|
4125.50 | 3406.00 | 2897.20 (42.40%) | Target met |
Buy
|
EARNINGS UPDATE-PI INDUSTRIES 2QFY22
Chola Wealth Direct
Background: Incorporated in 1947, PI (erstwhile Pesticides India) focuses on agri-input, custom synthesis and polymer compounding with strength of over 1,100 employees. The company currently operates three formulation and two manufacturing facilities as well as five multi-product plants across Gujarat and Jammu, and one R&D unit in Rajasthan at Udaipur. PI is one of India's leading players in the agri-input industry, primarily dealing in agro-chemicals, specialty fertilizers, plant...
|
|||
13 Nov 2021 | PI Industries |
ICICI Securities Limited
|
4125.50 | 3340.00 | 2737.85 (50.68%) | Target met |
Buy
|
||||
more
loading
|